Webcomm

2000s Renee Iacona, PhD’08, has been named AstraZeneca’s chief operating officer for oncology R&D in addition to her role as vice president of oncology biometrics. 2010s Nicole Perry-Hauser Nicole Perry-Hauser, PhD’19, has accepted a position as a lecturer, on a research and teaching track, at the School of Molecular Biosciences… Read More

The hard work of the faculty, staff, postdocs, and graduate students who conduct basic biomedical research at Vanderbilt continues to be recognized on the local and national level. Here we list a few of the researchers who have been recently celebrated. Tina Iverson (Pharmacology) received an Innovation Catalyst Fund award… Read More

By Alexandra Scammell The School of Medicine Basic Sciences consists of a remarkable community that is dedicated to advancing the study of human biology, health, and disease. In addition to the award-winning faculty and students who are at the forefront of our cutting-edge research, a large part of our school’s… Read More

By Herschel Pollard, edited by Marissa Shapiro and Lorena Infante Lara Vanderbilt University has received an $8.9 million grant from the National Institutes of Health to establish the Vanderbilt AUD Research and Education Center, bolstering the university’s leadership in neuroscience, addiction research, and innovative approaches to the study of alcohol… Read More

By Emily Hawes and Lorena Infante Lara The Vanderbilt University School of Medicine Basic Sciences encompasses four departments: Biochemistry, Cell and Developmental Biology, Molecular Physiology and Biophysics, and Pharmacology. Through this article series, we are featuring each one, highlighting their proudest accomplishments, unique strengths, and visions for the future. A… Read More

Alan Cherrington (Photo by Jamie McCormick) For more than 50 years, Vanderbilt has been a global leader in the quest to understand, prevent, and treat diabetes By Rachel Nuwer Alan Cherrington still clearly remembers the day that unexpectedly led him to what is today the Vanderbilt University School of Medicine Basic… Read More

Dean John Kuriyan (Photo by John Russell) Dear Alums and Friends, In the previous issue of Vestigo, we paused to look back at 150 years of innovative research. In this issue, we look ahead to new and amazing research breakthroughs coming out of our laboratories and their potential impact in… Read More

By Lorena Infante Lara The academic landscape can seem like an unmoving entity, but it’s the people within it that make it tick and grow to new frontiers. No outlook on our School of Medicine Basic Sciences is complete without recognizing significant faculty transitions, including well-deserved promotions, exciting new appointments,… Read More

Acanthamoeba can cause diseases blinding keratitis, an infection of the eye, or granulomatous amebic encephalitis, a generally fatal infection of the brain and spinal cord. Antifungals that target the biosynthesis of fungal sterols, such as ergosterol, are often used as treatment, but the Acanthamoeba ergosterol biosynthetic pathway has been shown to differ significantly from that found in fungi. Read More